Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02253225 · ClinicalTrials.gov registry record
Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study
A clinical trial of Bipolar Disorder and Major Depression, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT02253225 is a study of Bipolar Disorder and Major Depression that has completed, run by Massachusetts General Hospital. The registered enrollment target is 32 participants, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02253225, a study of Bipolar Disorder and Major Depression, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.
Conditions Studied
Interventions
- OTHER Functional Magnetic Resonance Imaging (fMRI)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-01 |
| Est. Completion | 2020-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02253225
The ClinicalTrials.gov registry entry for NCT02253225 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Functional Magnetic Resonance Imaging (fMRI) is the first listed.
NCT02253225 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02253225 about?
NCT02253225 is a clinical study titled "Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study". The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.
What is the current status of trial NCT02253225?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-01. Estimated completion is 2020-01.
What conditions does trial NCT02253225 study?
This clinical trial studies the following conditions: Bipolar Disorder, Major Depression, Rumination.
What interventions are being tested in trial NCT02253225?
The interventions under investigation include: Functional Magnetic Resonance Imaging (fMRI) (OTHER).
Who is sponsoring clinical trial NCT02253225?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02253225 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.